During a satellite symposium at the ERA-EDTA in Madrid, Spain, organised by PACE-CME, Marta Ruiz-Ortega sheds light on the new and exciting field of epigenetics, and how BET inhibition might provide an interesting therapeutic target in renal disease. She shares experimental data dat demonstrate the beneficial effects of BET inhibition.

Video navigation menu

Epigenetic mechanisms can determine health and disease, and can thus serve as therapeutic targets - an introduction to BET proteins 0:20

Mechanistic insights into the effects of BET inhibition from experimental studies 5:25